Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by teeveeon Feb 08, 2010 6:24pm
311 Views
Post# 16764315

RE: Re,Re: no MO for Dr. Fo

RE: Re,Re: no MO for Dr. Fo
"" Isotechnika has a limited amount of cash on hand to cover expenses.  It has at least, an eight month wait, before any more cash is available from Lux , if the NDA is successful.  Dr. Fo does not have very many friends left in the underwriting/institutional investor community.  They have  been burned too many times by   too many false promises and  unfulfilled hopes to put any more MO  behind the share price or into ISA / Dr.Fo's pockets!""
I agree that it is a very low probability that ISA could ever raise equity capital again. Didn't Paladin warn ISA shareholders that ISA must now find a way to stay cash flow positive, and if not, they would let it go down? Paladin owns all ISA patents and ISA just leases them back, so if ISA folds, Paladin retains 100% of patents plus any licencing milestone payments and royalties.   Perhaps there is a good reason why there is no insider buying?  
     
<< Previous
Bullboard Posts
Next >>